How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations August 14, 2024 Issue Brief Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…
2024 Women’s Health Survey August 14, 2024 Dashboard 2024 Women’s Health Survey The 2024 KFF Women’s Health Survey (WHS) is the latest in a series of nationally representative surveys on women’s health conducted by KFF since 2001. The survey’s objective is to track and document women’s experiences and knowledge related to health and well-being. The 2024 survey includes…
Similar Shares of Republican, Democratic, and Independent Women (One in Seven) Report Having Had an Abortion August 14, 2024 News Release A new nationally representative KFF Women’s Health Survey, which explores the extensive implications of Roe v. Wade being overturned by the Supreme Court, reveals that one in seven (14%) women of reproductive age report having had an abortion at some point in their life. Across partisanship, similar shares of Republican…
Women and Abortion in Florida: Findings from the 2024 KFF Women’s Health Survey August 14, 2024 Issue Brief This brief provides information about abortion experiences, awareness, and attitudes of Florida women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
Abortion Experiences, Knowledge, and Attitudes Among Women in the U.S.: Findings from the 2024 KFF Women’s Health Survey August 14, 2024 Issue Brief This brief provides new information from the 2024 KFF Women’s Health Survey about women’s experiences with abortion, the fallout of overturning Roe v. Wade, women’s knowledge about abortion laws in their states including medication abortion, as well as their opinions on the legality of abortion.
Women and Abortion in Arizona: Findings from the 2024 KFF Women’s Health Survey August 14, 2024 Issue Brief This brief provides information about abortion experiences, awareness, and attitudes of Arizona women ages 18 to 49, based on findings from the 2024 KFF Women’s Health Survey, a nationally representative survey on health care issues.
The Collision of Medicaid World Views August 12, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman writes about the fundamentally different world views of the Medicaid program by Republicans and Democrats and how those ideological divides have affected policy proposals, sometimes despite the program’s popularity and broad reach.
Medicare Advantage Plans Denied a Larger Share of Prior Authorization Requests in 2022 Than in Prior Years August 8, 2024 News Release Medicare Advantage plans denied 3.4 million prior authorization requests for health care services in whole or in part in 2022, or 7.4% of the 46.2 million requests submitted on behalf of enrollees that year, according to a new KFF analysis of federal data. That was a higher share of denials…
Medicare Advantage in 2024: Enrollment Update and Key Trends August 8, 2024 Issue Brief In 2024, more than half (54%) of eligible Medicare beneficiaries are enrolled in Medicare Advantage plans. This brief provides current information about Medicare Advantage enrollment, by plan type and firm, and shows how enrollment varies by state and county.
Medicare Advantage in 2024: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization August 8, 2024 Issue Brief This brief provides information about Medicare Advantage plans in 2024, including premiums, out-of-pocket limits, supplemental benefits, and prior authorization, as well as trends over time.